US researchers call for FDA action to avoid another EVALI outbreak.

Abstract

Researchers are calling for tighter US Food & Drug Administration (FDA) regulation of vaping products to avoid another outbreak of e-cigarette or vaping product use-associated lung injury (EVALI). EVALI hospitalised thousands of Americans starting in 2019, most of them teenagers or young adults, leaving many survivors with damaged lungs and persisting pulmonary dysfunction.